» Articles » PMID: 22700719

Common Variation at 6p21.31 (BAK1) Influences the Risk of Chronic Lymphocytic Leukemia

Abstract

We performed a meta-analysis of 3 genome-wide association studies to identify additional common variants influencing chronic lymphocytic leukemia (CLL) risk. The discovery phase was composed of genome-wide association study data from 1121 cases and 3745 controls. Replication analysis was performed in 861 cases and 2033 controls. We identified a novel CLL risk locus at 6p21.33 (rs210142; intronic to the BAK1 gene, BCL2 antagonist killer 1; P = 9.47 × 10(-16)). A strong relationship between risk genotype and reduced BAK1 expression was shown in lymphoblastoid cell lines. This finding provides additional support for polygenic inheritance to CLL and provides further insight into the biologic basis of disease development.

Citing Articles

The molecular map of CLL and Richter's syndrome.

Sud A, Parry E, Wu C Semin Hematol. 2024; 61(2):73-82.

PMID: 38368146 PMC: 11653080. DOI: 10.1053/j.seminhematol.2024.01.009.


Genome-wide Association Studies of Retinal Vessel Tortuosity Identify Numerous Novel Loci Revealing Genes and Pathways Associated With Ocular and Cardiometabolic Diseases.

Tomasoni M, Beyeler M, Ortin Vela S, Mounier N, Porcu E, Corre T Ophthalmol Sci. 2023; 3(3):100288.

PMID: 37131961 PMC: 10149284. DOI: 10.1016/j.xops.2023.100288.


The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review.

Kleinstern G, Slager S Leuk Lymphoma. 2022; 64(4):788-798.

PMID: 36576061 PMC: 10121840. DOI: 10.1080/10428194.2022.2157215.


Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.

Bagnara D, Mazzarello A, Ghiotto F, Colombo M, Cutrona G, Fais F Int J Mol Sci. 2022; 23(22).

PMID: 36430731 PMC: 9693457. DOI: 10.3390/ijms232214249.


Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.

Berndt S, Vijai J, Benavente Y, Camp N, Nieters A, Wang Z Leukemia. 2022; 36(12):2835-2844.

PMID: 36273105 PMC: 10337695. DOI: 10.1038/s41375-022-01711-0.


References
1.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

2.
Takeuchi O, Fisher J, Suh H, Harada H, Malynn B, Korsmeyer S . Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci U S A. 2005; 102(32):11272-7. PMC: 1183578. DOI: 10.1073/pnas.0504783102. View

3.
Conde L, Halperin E, Akers N, Brown K, Smedby K, Rothman N . Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010; 42(8):661-4. PMC: 2913472. DOI: 10.1038/ng.626. View

4.
Chittenden T, Harrington E, OConnor R, Flemington C, Lutz R, Evan G . Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 1995; 374(6524):733-6. DOI: 10.1038/374733a0. View

5.
Slager S, Rabe K, Achenbach S, Vachon C, Goldin L, Strom S . Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2010; 117(6):1911-6. PMC: 3056639. DOI: 10.1182/blood-2010-09-308205. View